Comparative RNA‐Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease
暂无分享,去创建一个
Felix Eichinger | M. Kretzler | J. Hur | E. Feldman | S. Pennathur | F. Brosius | L. Hinder | Meeyoung Park | Amy E. Rumora | Felix H. Eichinger
[1] F. Brosius. Determination of Podocyte Number and Density in Rodent Glomeruli v2 , 2019, protocols.io.
[2] Y. Lo,et al. Immunotherapy for diabetic amyotrophy. , 2017, The Cochrane database of systematic reviews.
[3] G. Boivin,et al. Protective role of CX3CR1 signalling in resident cells of the central nervous system during experimental herpes simplex virus encephalitis. , 2017, The Journal of general virology.
[4] R. Freeman,et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.
[5] M. Pellegrini,et al. Epigenetic changes in T‐cell and monocyte signatures and production of neurotoxic cytokines in ALS patients , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Kumar Sharma,et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. , 2016, JCI insight.
[7] R. Ransohoff,et al. CX3CR1‐dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation , 2016, European journal of immunology.
[8] Kevin M. Wheelock,et al. Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. , 2016, Journal of diabetes and its complications.
[9] J. Carpten,et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.
[10] C. Walker,et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis , 2016, Nature Medicine.
[11] Y. Li,et al. Matrix metalloproteinase 12 modulates high-fat-diet induced glomerular fibrogenesis and inflammation in a mouse model of obesity , 2016, Scientific Reports.
[12] E. Feldman,et al. Distal Symmetric Polyneuropathy: A Review. , 2015, JAMA.
[13] L. Welschen,et al. Prevalence and Correlates of Sexual Dysfunction in Men and Women With Type 2 Diabetes , 2015, Journal of sex & marital therapy.
[14] M. Guclu,et al. Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathy , 2015, Nephrology.
[15] A. Krolewski,et al. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[16] P. Wiffen,et al. Amitriptyline for neuropathic pain in adults. , 2015, The Cochrane database of systematic reviews.
[17] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] P. Low,et al. Orthostatic Hypotension: Mechanisms, Causes, Management , 2015, Journal of clinical neurology.
[19] D. Ziegler,et al. A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain , 2015, Pain.
[20] R. Dunn,et al. Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. , 2015, The Journal of urology.
[21] M. Kretzler,et al. The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes , 2015, Diabetes.
[22] Carol D Clair,et al. The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis , 2015, Journal of General Internal Medicine.
[23] M. Zhan,et al. Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance. , 2015, Journal of diabetes and its complications.
[24] Mohammad A. Dabbah,et al. Small Nerve Fiber Quantification in the Diagnosis of Diabetic Sensorimotor Polyneuropathy: Comparing Corneal Confocal Microscopy With Intraepidermal Nerve Fiber Density , 2015, Diabetes Care.
[25] Steven J. Brown,et al. Diabetic Peripheral Neuropathy Compromises Balance During Daily Activities , 2015, Diabetes Care.
[26] A. Bharucha. Epidemiology and natural history of gastroparesis. , 2015, Gastroenterology clinics of North America.
[27] Andreas Voss,et al. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey , 2015, Diabetologia.
[28] A. Napoli,et al. Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus , 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.
[29] J. Hur,et al. BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses , 2015, Neurobiology of Disease.
[30] P. Wiffen,et al. Nortriptyline for neuropathic pain in adults. , 2015, The Cochrane database of systematic reviews.
[31] R. Freeman,et al. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. , 2015, Brain : a journal of neurology.
[32] R. Hamman,et al. The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions , 2014, Diabetes Care.
[33] V. Montori,et al. Pharmacologic Interventions for Painful Diabetic Neuropathy , 2014, Annals of Internal Medicine.
[34] S. McGuire,et al. Centers for Disease Control and Prevention. State indicator report on Physical Activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. , 2014, Advances in nutrition.
[35] Nicholas A. Giovinco,et al. How to do a 3-minute diabetic foot exam. , 2014, The Journal of family practice.
[36] P. Wiffen,et al. Desipramine for neuropathic pain in adults. , 2014, The Cochrane database of systematic reviews.
[37] R. Pop-Busui,et al. Association Between Impaired Cardiovascular Autonomic Function and Hypoglycemia in Patients With Type 1 Diabetes , 2014, Diabetes Care.
[38] Yuanfang Guan,et al. Identification of Stage‐Specific Genes Associated With Lupus Nephritis and Response to Remission Induction in (NZB × NZW)F1 and NZM2410 Mice , 2014, Arthritis & rheumatology.
[39] R. Walker,et al. Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3* , 2014, The Journal of Biological Chemistry.
[40] A. Vinik,et al. A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.
[41] E. Feldman,et al. Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. , 2014, Antioxidants & redox signaling.
[42] Sandra P. Reyna,et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. , 2014, Journal of diabetes and its complications.
[43] R. Freeman,et al. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs , 2014, PAIN®.
[44] P. Raskin,et al. Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy: A Randomized Withdrawal Trial , 2013, The Clinical journal of pain.
[45] Jeffrey S. Gonzalez,et al. Recognition and management of psychosocial issues in diabetic neuropathy. , 2014, Handbook of clinical neurology.
[46] Benn Smith. Focal and entrapment neuropathies. , 2014, Handbook of clinical neurology.
[47] J. Stinson,et al. Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society , 2014, Pain research & management.
[48] G. Cruccu,et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain , 2013, PAIN®.
[49] W. Rathmann,et al. Association of Subclinical Inflammation With Polyneuropathy in the Older Population , 2013, Diabetes Care.
[50] E. Feldman,et al. The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities , 2013, Annals of neurology.
[51] A. Boulton,et al. Whither pathogenetic treatments for diabetic polyneuropathy? , 2013, Diabetes/metabolism research and reviews.
[52] A. Vinik,et al. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. , 2013, Clinical therapeutics.
[53] J. M. Suh,et al. PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.
[54] A. Morabito,et al. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. , 2013, The journal of sexual medicine.
[55] B. Kestenbaum,et al. Kidney disease and increased mortality risk in type 2 diabetes. , 2013, Journal of the American Society of Nephrology : JASN.
[56] P. Dyck,et al. Electrodiagnostic testing in lumbosacral plexopathies. , 2013, Physical medicine and rehabilitation clinics of North America.
[57] D. Bluemke,et al. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). , 2013, Journal of the American College of Cardiology.
[58] C. Mason,et al. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data , 2013, Genome Biology.
[59] S. Yusuf,et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND , 2010, Clinical Research in Cardiology.
[60] E. Feldman,et al. Biology of diabetic neuropathy. , 2013, Handbook of clinical neurology.
[61] E. Feldman,et al. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. , 2013, The Journal of endocrinology.
[62] Charlotte Soneson,et al. A comparison of methods for differential expression analysis of RNA-seq data , 2013, BMC Bioinformatics.
[63] P. Wiffen. ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012 .
[64] S. Appel,et al. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms , 2012, Neurobiology of Disease.
[65] A. Davis,et al. Transient Brown Adipocyte‐Like Cells Derive from Peripheral Nerve Progenitors in Response to Bone Morphogenetic Protein 2 , 2012, Stem cells translational medicine.
[66] M. Blankenburg,et al. Childhood diabetic neuropathy: functional impairment and non‐invasive screening assessment , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[67] N. Staff,et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. , 2012, Brain : a journal of neurology.
[68] P. Wiffen,et al. COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS , 2012, The Cochrane database of systematic reviews.
[69] J. Albers,et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[70] H. Huikuri,et al. Autonomic Cardiac Regulation During Spontaneous Nocturnal Hypoglycemia in Patients With Type 1 Diabetes , 2012, Diabetes Care.
[71] I. Evdokimidis,et al. Alterations of T cell subsets in ALS: a systemic immune activation? , 2012, Acta neurologica Scandinavica.
[72] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[73] P. Barter,et al. The emerging role of HDL in glucose metabolism , 2012, Nature Reviews Endocrinology.
[74] L. Melton,et al. Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population , 2012, The American Journal of Gastroenterology.
[75] Malin,et al. Randomized , Placebo-Controlled Comparison of Amitriptyline , Duloxetine , and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain Impact on pain , polysomnographic sleep , daytime functioning , and quality of life , 2012 .
[76] E. Feldman,et al. Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. , 2011, Endocrinology.
[77] G. Stoll,et al. Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment , 2011, Acta Neuropathologica.
[78] A. Vinik,et al. Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.
[79] P. Pasricha,et al. Psychological Dysfunction Is Associated With Symptom Severity but Not Disease Etiology or Degree of Gastric Retention in Patients With Gastroparesis , 2010, The American Journal of Gastroenterology.
[80] E. Feldman,et al. The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice , 2010, Neuroscience Letters.
[81] L. S. Tan. The clinical use of the 10g monofilament and its limitations: a review. , 2010, Diabetes research and clinical practice.
[82] C. Schmitz,et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study , 2010, Journal of the peripheral nervous system : JPNS.
[83] M. Duan,et al. Repeated administration of pioglitazone attenuates development of hyperalgesia in a rat model of neuropathic pain. , 2010, Experimental and clinical psychopharmacology.
[84] Y. Kadoi. Perioperative considerations in diabetic patients. , 2010, Current diabetes reviews.
[85] D. Giugliano,et al. Determinants of female sexual dysfunction in type 2 diabetes , 2010, International Journal of Impotence Research.
[86] J. Fleg,et al. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.
[87] D. Giugliano,et al. Determinants of erectile dysfunction in type 2 diabetes , 2010, International Journal of Impotence Research.
[88] L. Marciani,et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[89] K. Dhatariya. Sexual Dysfunction in Women With Type 1 Diabetes: Long-Term Findings From the DCCT/EDIC Study Cohort , 2010, Diabetes Care.
[90] R. Pop-Busui. Cardiac Autonomic Neuropathy in Diabetes A clinical perspective , 2010 .
[91] Ralf Baron,et al. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms , 2009, PAIN.
[92] P. Wiffen,et al. Pregabalin for acute and chronic pain in adults. , 2009, The Cochrane database of systematic reviews.
[93] J. Albers,et al. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.
[94] V. Drory,et al. Low‐grade systemic inflammation in patients with amyotrophic lateral sclerosis , 2009, Acta neurologica Scandinavica.
[95] R. Rubin,et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study , 2009, Diabetologia.
[96] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[97] D. Sviridov,et al. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. , 2009, Journal of the American College of Cardiology.
[98] R. Pop-Busui,et al. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort , 2009, Journal of the peripheral nervous system : JPNS.
[99] W. Rathmann,et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. , 2009, Pain medicine.
[100] T. Le,et al. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain , 2009, BMC neurology.
[101] A. Deshpande,et al. Epidemiology of Diabetes and Diabetes-Related Complications , 2008, Physical Therapy.
[102] S. Appel,et al. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS , 2008, Proceedings of the National Academy of Sciences.
[103] E. Feldman,et al. Diabetic neuropathy: mechanisms to management. , 2008, Pharmacology & therapeutics.
[104] D. Cha,et al. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[105] M. Hanna,et al. Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients , 2008, European journal of pain.
[106] M. Kretzler,et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. , 2008, American journal of physiology. Renal physiology.
[107] R. Freeman,et al. Clinical practice. Neurogenic orthostatic hypotension. , 2008, The New England journal of medicine.
[108] H. Parving,et al. A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes , 2008, Scandinavian journal of clinical and laboratory investigation.
[109] R. DeFronzo,et al. Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.
[110] D. Ziegler. Autonomic neuropathy in diabetes , 2008 .
[111] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[112] E. Feldman,et al. Mouse models of diabetic neuropathy , 2007, Neurobiology of Disease.
[113] A. Mildner,et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.
[114] F. Rossi,et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.
[115] J. Farrar,et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.
[116] B. Segal. The role of natural killer cells in curbing neuroinflammation , 2007, Journal of Neuroimmunology.
[117] P. Wiffen,et al. Antidepressants for neuropathic pain. , 2007, The Cochrane database of systematic reviews.
[118] Giuseppe Lauria,et al. Skin biopsy as a diagnostic tool in peripheral neuropathy , 2007, Nature Clinical Practice Neurology.
[119] D. Betteridge,et al. Effects of pioglitazone on lipid and lipoprotein metabolism , 2007, Diabetes, obesity & metabolism.
[120] J. Højsted,et al. Addiction to opioids in chronic pain patients: A literature review , 2007, European journal of pain.
[121] D. Resnick,et al. Thiazolidinedione Class of Peroxisome Proliferator-Activated Receptor γ Agonists Prevents Neuronal Damage, Motor Dysfunction, Myelin Loss, Neuropathic Pain, and Inflammation after Spinal Cord Injury in Adult Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.
[122] M. Camilleri. Clinical practice. Diabetic gastroparesis. , 2007, The New England journal of medicine.
[123] B. Galer,et al. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. , 2007, The journal of pain : official journal of the American Pain Society.
[124] S. Daniels,et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. , 2007, Archives of pediatrics & adolescent medicine.
[125] J. Benneyan,et al. Foundations of Opioid Risk Management , 2007, The Clinical journal of pain.
[126] Bridget A. Martell,et al. Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.
[127] S. Shalitin,et al. Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes. , 2007, Journal of diabetes and its complications.
[128] J. Wernicke,et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain , 2006, Neurology.
[129] T. Best,et al. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. , 2006, Journal of athletic training.
[130] M. McGrath,et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS) , 2006, Journal of Neuroimmunology.
[131] S. Daniels,et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. , 2006, The Journal of pediatrics.
[132] D. Goldstein,et al. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. , 2006, Pain medicine.
[133] James Albers,et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.
[134] H. Parving,et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. , 2006, Diabetes care.
[135] B. Göke,et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans , 2005, Gut.
[136] T. Wilt,et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. , 2006, Archives of internal medicine.
[137] J. Leahy. A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia , 2006 .
[138] L. Hyllienmark,et al. Early Diabetic Complications in a Population of Young Patients with Type 1 Diabetes Mellitus Despite Intensive Treatment , 2006, Journal of pediatric endocrinology & metabolism : JPEM.
[139] C. Münz,et al. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. , 2006, European journal of immunology.
[140] Howard Leventhal,et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. , 2005, Diabetes care.
[141] M. Detke,et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.
[142] E. Whalen,et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens , 2005, Pain.
[143] M. Kretzler,et al. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[144] Michael Brownlee,et al. The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.
[145] L. Plaghki,et al. Critical review of oral drug treatments for diabetic neuropathic pain—clinical outcomes based on efficacy and safety data from placebo‐controlled and direct comparative studies , 2005, Diabetes/metabolism research and reviews.
[146] Alfonso T. Perez,et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. , 2005, Diabetes care.
[147] L. Lamoreaux,et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. , 2005, The journal of pain : official journal of the American Pain Society.
[148] C. Pollock,et al. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. , 2005, Journal of the American Society of Nephrology : JASN.
[149] Heikki V Huikuri,et al. Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes. , 2005, Diabetes.
[150] D. Selvarajah,et al. Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.
[151] German Diabetes Association , 2005, Diabetologia.
[152] S. Weigand,et al. Autonomic symptoms and diabetic neuropathy: a population-based study. , 2004, Diabetes care.
[153] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[154] T. Nurmikko,et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[155] M. Rowbotham,et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study , 2004, Pain.
[156] J. Rosenstock,et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.
[157] P. Fratino,et al. Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients , 2004, Circulation.
[158] J. Arezzo,et al. Diabetic somatic neuropathies. , 2004, Diabetes care.
[159] R. Rubin,et al. Psychological aspects of diabetic neuropathic foot complications: an overview , 2004, Diabetes/metabolism research and reviews.
[160] M. Detke,et al. Effects of duloxetine on painful physical symptoms associated with depression. , 2004, Psychosomatics.
[161] K. Murray,et al. Cyclic antidepressants and the risk of sudden cardiac death , 2004, Clinical pharmacology and therapeutics.
[162] S. Sindrup,et al. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function , 1990, European Journal of Clinical Pharmacology.
[163] N. Harris,et al. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes , 2004, Diabetologia.
[164] M. Samsom,et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. , 2003, Diabetes care.
[165] R. Wiggins,et al. Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. , 2003, Journal of the American Society of Nephrology : JASN.
[166] A. Gordon,et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy , 2003, Pain.
[167] Braxton D Mitchell,et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.
[168] T. Jensen,et al. Venlafaxine versus imipramine in painful polyneuropathy , 2003, Neurology.
[169] R. Portenoy,et al. Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.
[170] Jaime Caro,et al. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. , 2003, Clinical therapeutics.
[171] Miroslav Backonja,et al. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. , 2003, Clinical therapeutics.
[172] DOUGLAS G. Smith,et al. Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer. , 2002, Diabetes care.
[173] B. Perkins,et al. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. , 2002, Diabetes care.
[174] A. Boulton,et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[175] Jarkko Venna,et al. Analysis and visualization of gene expression data using Self-Organizing Maps , 2002, Neural Networks.
[176] G. Biessels,et al. Ageing and diabetes: implications for brain function. , 2002, European journal of pharmacology.
[177] A. Windebank,et al. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment , 2002, Muscle & nerve.
[178] K. Demyttenaere,et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. , 2002, Diabetes care.
[179] Douglas G Altman,et al. Guidelines for the design and statistical analysis of experiments using laboratory animals. , 2002, ILAR journal.
[180] D. A. Simpson. Gabapentin and Venlafaxine for the Treatment of Painful Diabetic Neuropathy , 2001, Journal of clinical neuromuscular disease.
[181] S. Tesfaye,et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.
[182] T. Nakamura,et al. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. , 2001, Metabolism: clinical and experimental.
[183] M. Horowitz,et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. , 2001, Archives of internal medicine.
[184] B. Beaufrère,et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. , 2001, The American journal of clinical nutrition.
[185] R. Sorelle. US Department of Health and Human Services gives states wider latitude in choosing services to be covered by Medicaid. , 2001, Circulation.
[186] R. Koup,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy , 2001, Journal of Virology.
[187] B. Zinman,et al. Simple screening tests for peripheral neuropathy in the diabetes clinic. , 2000, Diabetes care.
[188] S. J. Smith,et al. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. , 2000, Clinical chemistry.
[189] T. Jensen,et al. Pharmacologic treatment of pain in polyneuropathy , 2000, Neurology.
[190] D. Kimmig,et al. The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils , 2000, European journal of immunology.
[191] P. Mazzarello,et al. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. , 2000, Journal of pain and symptom management.
[192] C. Hensey,et al. Gremlins, glomeruli and diabetic nephropathy< , 2000, Current opinion in nephrology and hypertension.
[193] T. Nakamura,et al. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. , 2000, Journal of diabetes and its complications.
[194] P. Raskin,et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. , 2000, Journal of diabetes and its complications.
[195] A. Windebank,et al. Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes , 1999, Neurobiology of Disease.
[196] S. Leckband,et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. , 1999, Archives of internal medicine.
[197] J. Joss. Tricyclic Antidepressant Use in Diabetic Neuropathy , 1999, The Annals of pharmacotherapy.
[198] P. Törönen,et al. Analysis of gene expression data using self‐organizing maps , 1999, FEBS letters.
[199] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[200] A. Beydoun,et al. Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .
[201] F. Parazzini,et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. , 1998, Diabetes care.
[202] P C O'Brien,et al. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects , 1997, Muscle & nerve.
[203] J. Sutton,et al. Opioid‐induced Delay in Gastric Emptying: A Peripheral Mechanism in Humans , 1997, Anesthesiology.
[204] Jefferson Luiz Brum Marques,et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[205] M. Horowitz,et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. , 1997, Gastroenterology.
[206] T. Ueda,et al. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. , 1997, The Journal of urology.
[207] J. Shaw,et al. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating , 1997, Diabetologia.
[208] J. Shaw,et al. Gustatory Sweating in Diabetes Mellitus , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[209] S. P. Singh,et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. , 1995, Advances in therapy.
[210] M B Brown,et al. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.
[211] H A Feldman,et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.
[212] B. Lindkvist,et al. Hypoglycaemia Increases the Gastric Emptying Rate in Patients with Type 1 Diabetes Mellitus , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[213] J. Bigger,et al. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. , 1993, JAMA.
[214] R Dubner,et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.
[215] R. Shank,et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. , 1992, The Journal of pharmacology and experimental therapeutics.
[216] J. Dent,et al. Hyperglycaemia stimulates pyloric motility in normal subjects. , 1991, Gut.
[217] R. Dubner,et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial , 1991, Pain.
[218] C. Jf,et al. [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.
[219] E. Bass,et al. Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study , 1989, Diabetes.
[220] R. Dubner,et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood , 1987, Neurology.
[221] R. D'Agostino. Transformation to normality of the null distribution of g1 , 1970 .